According to the manufacturer of Bapten, a drug used for the treatment of tendinitis of the superficial digital flexor tendon in the horse, the drug is again on the market. There was a “stop-sale” on Bapten in Oct. 1998 due to “a small number of reports of apparent excessive swelling post treatment,” according to Boehringer Ingelheim.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.To continue reading this article, become a member of TheHorse.com.









